lncRNA CASC2 Enhances (131)I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155

Long noncoding RNA cancer susceptibility candidate 2 (CASC2) has been reported to play an anticancer role in papillary thyroid cancer (PTC). Radioiodine ((131)I) is a common option for the treatment of PTC. However, the role and mechanism of CASC2 in (131)I sensitivity remain unclear. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Ling, Tian, Ping, Yang, Li, Guo, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591961/
https://www.ncbi.nlm.nih.gov/pubmed/33134385
http://dx.doi.org/10.1155/2020/7183629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591961/
https://www.ncbi.nlm.nih.gov/pubmed/33134385
http://dx.doi.org/10.1155/2020/7183629

Ejemplares similares